1,4-oxazepane hydrochloride,
178312-62-4,
homomorpholine hydrochloride,
1,4-Oxazepine, hexahydro-, hydrochloride,
HOMOMORPHOLINE HCL,
MFCD02683070,
1,4-Oxazepan hydrochloride,
[1,4]oxazepane hydrochloride,
hexahydro-1,4-Oxazepine hydrochloride,
homomorpholine-hydrochloride,
1,4-oxazepane,hydrochloride,
homo-morpholine hydrochloride,
homomorph-oline hydrochloride,
1,4-Axazepane hydrochloride,
SCHEMBL58640,
CTK8B4985,
DTXSID70630494,
LJRCWNIWOVZLKS-UHFFFAOYSA-N,
HT472,
CS-B1101,
EBD53556,
ANW-46957,
HT1123,
AKOS015848578,
RP08335,
RTR-008173,
VZ32380,
Homomorpholine hydrochloride, AldrichCPR,
KS-000000X4,
AK-81388,
DS-16215,
SC-43925,
SY002594,
1,4-Oxazepane--hydrogen chloride (1/1),
AB0079702,
ST2414874,
TL8006240,
TR-008173,
4CH-000720,
AM20090058,
FT-0084799,
FT-0643727,
178312-62-4 1,4-oxazepane hydrochloride,
Z-0568,
MFCD02683070 (97+%),
1,4-Oxazepine, hexahydro-, hydrochloride (1:1),
312H624,
W-206255,
I14-20357,
I14-20426,
F1905-6472,
(R)-N-Fmoc-4-Fluorophenylalanine; Fmoc-D-4-Fluorophe; Fmoc-p-fluoro-D-Phe-OH; Fmoc-D-Phe(4-F)-OH; Fluorenylmethoxycarbonyl-D-4-fluorophenylalanine,
1-2 weeks,
Homomorpholine hydrochloride, 98% 1g,
ACN-045564,